hVIVO buys CRS Berlin as expands into dermatology and women's health
(Alliance News) - hVIVO PLC on Thursday announced the acquisition of a clinical research unit to expand its expertise into dermatology and women's health markets. Read More
| Price | 6.55p on 28-08-2026 at 17:35:13 |
|---|---|
| Change | 0.10p 1.54% |
| Buy | 6.60p |
| Sell | 6.50p |
| Last Trade: | Unknown 25,000.00 at 6.60p |
| Day's Volume: | 750,244 |
| Last Close: | 6.60p |
| Open: | 6.50p |
| ISIN: | GB00B9275X97 |
| Day's Range | 6.55p - 6.60p |
| 52wk Range: | 4.35p - 10.15p |
| Market Capitalisation: | £45.43m |
| VWAP: | 6.514283p |
| Shares in Issue: | 688.40m |
Sector: Health Care and Related Services
Listed In: FTSE AIM 100, FTSE AIM All-Share,
hVIVO (HVO) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 25,000 | 6.60p | OTC Trade |
17:05:41 - 28-Aug-26 |
| Buy* | 2,000 | 6.60p | Suspected BUY Trade |
16:35:17 - 28-Aug-26 |
| Sell* | 40,650 | 6.51p | Ordinary |
15:57:50 - 28-Aug-26 |
| Sell* | 50,568 | 6.51p | Ordinary |
15:32:51 - 28-Aug-26 |
| Buy* | 7,610 | 6.5695p | Ordinary |
15:12:57 - 28-Aug-26 |
| Sell* | 6,686 | 6.51p | Ordinary |
15:01:20 - 28-Aug-26 |
| Buy* | 20 | 6.60p | Ordinary |
14:45:47 - 28-Aug-26 |
| Sell* | 52,220 | 6.50p | Ordinary |
14:39:44 - 28-Aug-26 |
| Buy* | 25,000 | 6.5695p | Ordinary |
14:19:41 - 28-Aug-26 |
| Buy* | 20,000 | 6.60p | Suspected BUY Trade |
14:00:08 - 28-Aug-26 |
hVIVO (HVO) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 27th Aug 2026 7:00 am | RNS | hVIVO acquires CRS Berlin |
| 23rd Jul 2026 7:00 am | RNS | H1 2026 Trading Update |
| 13th Jul 2026 7:00 am | RNS | Change of Auditor |
| 9th Jun 2026 7:00 am | RNS | Holding(s) in Company |
| 1st Jun 2026 12:00 pm | RNS-R | Consultancy contract with Decoy Therapeutics |
| 29th May 2026 7:00 am | RNS | Grant of awards under Long Term Incentive Plan |
| 20th May 2026 7:00 am | RNS | Capital Markets Day |
| 13th May 2026 1:40 pm | RNS | Result of AGM |
| 12th May 2026 9:45 am | RNS | Holding(s) in Company |
| 7th May 2026 7:00 am | RNS | £6m Influenza HCT contract signed |